UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 7, 2008
DexCom, Inc.
(Exact Name of the Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
000-51222 |
|
33-0857544 |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
5555 Oberlin Drive, San Diego, CA |
|
92121 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
(858) 200-0200
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01: Regulation FD Disclosure.
On Monday, January 7, 2008, DexCom, Inc. (“DexCom”) issued a press release announcing that it has entered into a development and supply agreement with Insulet Corporation (“Insulet”) to integrate DexCom’s continuous glucose monitoring technology into Insulet’s wireless, handheld OmniPod System Personal Diabetes Manager. A copy of the press release is attached to this report as Exhibit 99.01.
Item 9.01: Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
|
Description of Exhibit |
|
|
|
99.01 |
|
Press release dated January 7, 2008 regarding DexCom’s entry into a development and supply agreement with Insulet Corporation. |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
DEXCOM, INC. |
||
|
|
|
|
|
By: |
/s/ Steven R. Pacelli |
|
|
|
Steven R. Pacelli |
|
Date: January 7, 2008
3
EXHIBIT INDEX
Exhibit |
|
Description of Exhibit |
|
|
|
99.01 |
|
Press release dated January 7, 2008 regarding DexCom’s entry into a development and supply agreement with Insulet Corporation. |
4